Free teaser · full plain English is Pro — see pricing

CompanyShort-termNeutralDays to weeksCompanyNVO 

Novo Nordisk A/S - share repurchase programme

  • Novo Nordisk is using its strong cash flow to buy back shares, tightening equity and potentially lifting earnings per share.
  • DKK 15 billion total programme cap
  • DKK 11.2 billion B‑share tranche
  • 41,714,179 B shares repurchased

Novo Nordisk announced it has begun a share repurchase programme that can spend up to DKK 15 billion over 12 months starting 4 February 2026. The programme, launched on 6 May 2026, allows the company to buy back B‑class shares for up to DKK 11.2 billion until 1 February 2027. By 2 November 2026, Novo had repurchased 41,714,179 B shares at an average price of DKK 277.23, spending DKK 11,564,364,801. The company now holds 55,754,876 treasury B shares, about 1.2 % of its total share capital.

The buy‑back signals Novo Nordisk’s confidence in its cash flow and long‑term value. It reduces the number of shares outstanding, which can lift earnings per share and support the stock price. The programme also demonstrates the company’s willingness to return capital to shareholders while maintaining a large cash…

Short-term. Over the next few weeks, the stock may react to the pace of the buy‑back.

Longer-term. For investors looking ahead, the buy‑back confirms Novo’s confidence in its long‑term prospects and its ability to generate excess cash.

Words on this card

B shares
A class of shares issued by Novo Nordisk that trade on Nasdaq Copenhagen and have a par value of DKK 0.10.
Treasury shares
Shares that a company has repurchased and holds in its own treasury; they are not considered outstanding.
Regulation No 596/2014 (MAR)
European Market Abuse Regulation that governs share repurchase programmes.
Safe Harbour Rules
EU rules that provide a safe harbour for companies conducting share buy‑backs under certain conditions.
EPS Learn
Earnings per share — profit for one share of the company, in dollars.
Earnings Learn
A company’s results report — usually profit and sales for a quarter, plus any update on what comes next.

ClearTape summarizes context in-app. For the full publisher article, use Read original source above.